Viewing Study NCT02441803


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-23 @ 1:12 AM
Study NCT ID: NCT02441803
Status: COMPLETED
Last Update Posted: 2024-02-22
First Post: 2015-05-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Acute myeloid leukemia View
None AML View
None Refractory View
None Allogeneic hematopoietic stem cell transplantation View
None AHSCT View
None Busulfan View
None Busulfex View
None Myleran View
None Fludarabine View
None Fludarabine Phosphate View
None Fludara View
None Clofarabine View
None Clofarex View
None Clolar View
None Total body irradiation View
None TBI View
None XRT View
None Thymoglobulin View
None ATG (Rabbit) View
None Rabbit antithymocyte Globulin View
None Rabbit Antilymphocyte Globulin View
None Rabbit ATG View
None rATG View
None Stem cell infusion View
None Cyclophosphamide View
None Cytoxan View
None Neosar View
None Tacrolimus View
None Prograf View
None Mycophenolate mofetil View
None MMF View
None CellCept View
None Decitabine View
None Dacogen View
None Cytarabine View
None Ara-C View
None Cytosar View
None DepoCyt View
None Cytosine Arabinosine Hydrochloride View
None Idarubicin View
None Idamycin View